港股收評:恆科指反彈3% 恆指跌0.1% 君實生物放量升超20%
格隆匯10月25日丨受隔夜美股上漲提振,港股早盤探底回升,恆生科技指數一度漲超6%,收漲2.96%,恆指小幅下跌0.1%,國指漲1.29%,三者均止步昨日的大跌行情。盤面上,大型科技股領銜市場反彈,京東漲5%,快手、小米漲4.5%,網易、美團、阿里巴巴、百度均有漲幅;互聯網醫療股全天表現強勢,餐飲股、煤炭股、光伏股、航空股、家電股、體育用品股普遍上漲,在線教育股新東方在線漲11.6%,表現搶眼。另一方面,香港本地銀行股大跌,匯豐控股績後跌超5%,中醫藥股下跌明顯,內房股與物管股普跌。個股方面,君實生物大漲超20%,公司新冠口服藥VV116多項國際多中心註冊臨牀研究正在進行;康希諾生物尾盤拉昇漲近9%,啓動吸入用重組新冠病毒疫苗(5型腺病毒載體)加強免疫接種。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.